Welcome to our dedicated page for Embecta news (Ticker: EMBC), a resource for investors and traders seeking the latest updates and insights on Embecta stock.
Embecta Corp. reports news on its medical supplies business, centered on insulin delivery products and diabetes-care devices. The company sells pen needles, syringes and safety devices through wholesalers, distributors and institutional channels, and it has described a transition from insulin delivery toward a broader medical supplies platform.
Recurring updates include quarterly operating and financial results, cash dividend declarations, conference participation, board leadership changes, operational updates, capital-structure matters, material agreements, and regulatory or clinical disclosures tied to its device portfolio and manufacturing activities.
embecta (Nasdaq: EMBC) announced that its management will participate in two upcoming investor conferences. At the Wells Fargo 2026 Healthcare Conference, management will hold one-on-one investor meetings on September 9, 2026, at the Encore Boston Harbor Hotel in Everett, Boston, MA. At the J.P. Morgan 4th Annual Nashville Healthcare Conference 2026, management will host a fireside chat on September 10, 2026, at 8:00 a.m. CT, and conduct one-on-one meetings at the Joseph Hotel in Nashville.
embecta (Nasdaq: EMBC) announced that its Board of Directors has declared a quarterly cash dividend of $0.01 per issued and outstanding share of common stock. The dividend will be payable on September 15, 2026 to stockholders of record as of the close of business on August 27, 2026.
embecta (Nasdaq: EMBC) will host a conference call at 8:00 a.m. ET on Friday, August 7, 2026 to discuss its fiscal third quarter 2026 financial results, provide an operational update, and hold a Q&A session. The live webcast and teleconference can be accessed via links and through the embecta investor relations website, with a replay available from 11:00 a.m. ET on August 7, 2026 and archived for one year.
embecta (Nasdaq: EMBC) appointed Nimish Muzumdar as Senior Vice President and President, North America, effective June 15, 2026. He will lead U.S. and Canada commercial teams and regional growth strategy, reporting to the CEO.
Muzumdar previously led a $1 billion Sandoz division and received an inducement award of 638,978 RSUs, vesting over three years.
embecta (Nasdaq: EMBC) announced management will participate in several June 2026 healthcare investor events in the U.S.
These include conferences hosted by Jefferies, TD Cowen, Goldman Sachs, and Truist Securities, featuring one-on-one investor meetings and a fireside session across New York, New Orleans, Miami, and Boston.
embecta (Nasdaq: EMBC) has completed its acquisition of Owen Mumford Holdings, a UK-based medical device and drug delivery innovator. The deal includes a £100 million upfront cash payment and up to £50 million in performance-based payments tied to Aidaptus® auto-injector net sales.
The transaction is intended to accelerate embecta’s shift into a broad medical supplies and drug delivery platforms business, expanding its chronic care product portfolio, intellectual property, manufacturing capabilities, and global commercial reach across obesity, diabetes, autoimmune diseases and anaphylaxis markets.
Embecta (Nasdaq: EMBC) will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET. Audio webcasts will be available via the News & Events section of the company's investor relations site at investors.embecta.com.
embecta (Nasdaq: EMBC) declared a quarterly cash dividend of $0.01 per share. The dividend is payable on June 15, 2026 to shareholders of record at the close of business on May 28, 2026.
Embecta (Nasdaq: EMBC) reported second quarter fiscal 2026 financial results and announced an analyst and investor conference call and live webcast on May 5, 2026 at 8:00 a.m. ET. A webcast replay will be available beginning at 11:00 a.m. ET on May 5, 2026 and archived for one year on the investor website.
Investors are directed to the company investor relations site for the full earnings press release and presentation.